Selected research
Market Structure
Global Cardiovascular Diagnostic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cardiovascular Diagnostic Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cardiovascular Diagnostic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cardiovascular Diagnostic Testing include Abbott Laboratories, BD, bioMérieux, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche, PerkinElmer, Siemens AG and Tosoh Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Cardiovascular Diagnostic Testing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cardiovascular Diagnostic Testing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cardiovascular Diagnostic Testing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiovascular Diagnostic Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
Cardiovascular Diagnostic Testing Segment by Company
Abbott Laboratories
BD
bioMérieux
Bio-Rad Laboratories
Danaher Corporation
F. Hoffmann-La Roche
PerkinElmer
Siemens AG
Tosoh Corporation
Thermo Fisher Scientific
Cardiovascular Diagnostic Testing Segment by Type
Fibrinogen Test
Angiotensin Test
Serum Uric Acid Test
Lipoprotein Test
Cardiovascular Diagnostic Testing Segment by Application
Laboratory Testing Facilities
Point-of-care Testing Facilities
Cardiovascular Diagnostic Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Diagnostic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Diagnostic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Diagnostic Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cardiovascular Diagnostic Testing market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular Diagnostic Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiovascular Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cardiovascular Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Fibrinogen Test
- Angiotensin Test
- Serum Uric Acid Test
- Lipoprotein Test
Applications
- Laboratory Testing Facilities
- Point-of-care Testing Facilities
Companies covered
- Abbott Laboratories
- BD
- bioMérieux
- Bio-Rad Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche
- PerkinElmer
- Siemens AG
- Tosoh Corporation
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cardiovascular Diagnostic Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cardiovascular Diagnostic Testing Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cardiovascular Diagnostic Testing Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cardiovascular Diagnostic Testing Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cardiovascular Diagnostic Testing Market Dynamics
- 2.1 Cardiovascular Diagnostic Testing Industry Trends
- 2.2 Cardiovascular Diagnostic Testing Industry Drivers
- 2.3 Cardiovascular Diagnostic Testing Industry Opportunities and Challenges
- 2.4 Cardiovascular Diagnostic Testing Industry Restraints
3 Cardiovascular Diagnostic Testing Market by Manufacturers
- 3.1 Global Cardiovascular Diagnostic Testing Revenue by Manufacturers (2021-2026)
- 3.2 Global Cardiovascular Diagnostic Testing Sales by Manufacturers (2021-2026)
- 3.3 Global Cardiovascular Diagnostic Testing Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cardiovascular Diagnostic Testing Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cardiovascular Diagnostic Testing Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cardiovascular Diagnostic Testing Manufacturers, Product Type & Application
- 3.7 Global Cardiovascular Diagnostic Testing Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cardiovascular Diagnostic Testing Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cardiovascular Diagnostic Testing Players Market Share by Revenue in 2025
- 3.8.3 2025 Cardiovascular Diagnostic Testing Tier 1, Tier 2, and Tier 3
4 Cardiovascular Diagnostic Testing Market by Type
- 4.1 Cardiovascular Diagnostic Testing Type Introduction
- 4.1.1 Fibrinogen Test
- 4.1.2 Angiotensin Test
- 4.1.3 Serum Uric Acid Test
- 4.1.4 Lipoprotein Test
- 4.2 Global Cardiovascular Diagnostic Testing Sales by Type
- 4.2.1 Global Cardiovascular Diagnostic Testing Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cardiovascular Diagnostic Testing Sales by Type (2021-2032)
- 4.2.3 Global Cardiovascular Diagnostic Testing Sales Market Share by Type (2021-2032)
- 4.3 Global Cardiovascular Diagnostic Testing Revenue by Type
- 4.3.1 Global Cardiovascular Diagnostic Testing Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cardiovascular Diagnostic Testing Revenue by Type (2021-2032)
- 4.3.3 Global Cardiovascular Diagnostic Testing Revenue Market Share by Type (2021-2032)
5 Cardiovascular Diagnostic Testing Market by Application
- 5.1 Cardiovascular Diagnostic Testing Application Introduction
- 5.1.1 Laboratory Testing Facilities
- 5.1.2 Point-of-care Testing Facilities
- 5.2 Global Cardiovascular Diagnostic Testing Sales by Application
- 5.2.1 Global Cardiovascular Diagnostic Testing Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cardiovascular Diagnostic Testing Sales by Application (2021-2032)
- 5.2.3 Global Cardiovascular Diagnostic Testing Sales Market Share by Application (2021-2032)
- 5.3 Global Cardiovascular Diagnostic Testing Revenue by Application
- 5.3.1 Global Cardiovascular Diagnostic Testing Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cardiovascular Diagnostic Testing Revenue by Application (2021-2032)
- 5.3.3 Global Cardiovascular Diagnostic Testing Revenue Market Share by Application (2021-2032)
6 Global Cardiovascular Diagnostic Testing Sales by Region
- 6.1 Global Cardiovascular Diagnostic Testing Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cardiovascular Diagnostic Testing Sales by Region (2021-2032)
- 6.2.1 Global Cardiovascular Diagnostic Testing Sales by Region (2021-2026)
- 6.2.2 Global Cardiovascular Diagnostic Testing Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cardiovascular Diagnostic Testing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cardiovascular Diagnostic Testing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cardiovascular Diagnostic Testing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cardiovascular Diagnostic Testing Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cardiovascular Diagnostic Testing Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cardiovascular Diagnostic Testing Revenue by Region
- 7.1 Global Cardiovascular Diagnostic Testing Revenue by Region
- 7.1.1 Global Cardiovascular Diagnostic Testing Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cardiovascular Diagnostic Testing Revenue by Region (2021-2026)
- 7.1.3 Global Cardiovascular Diagnostic Testing Revenue by Region (2027-2032)
- 7.1.4 Global Cardiovascular Diagnostic Testing Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cardiovascular Diagnostic Testing Revenue (2021-2032)
- 7.2.2 North America Cardiovascular Diagnostic Testing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cardiovascular Diagnostic Testing Revenue (2021-2032)
- 7.3.2 Europe Cardiovascular Diagnostic Testing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cardiovascular Diagnostic Testing Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cardiovascular Diagnostic Testing Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cardiovascular Diagnostic Testing Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cardiovascular Diagnostic Testing Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Information
- 8.1.2 Abbott Laboratories Business Overview
- 8.1.3 Abbott Laboratories Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Laboratories Cardiovascular Diagnostic Testing Product Portfolio
- 8.1.5 Abbott Laboratories Recent Developments
- 8.2 BD
- 8.2.1 BD Company Information
- 8.2.2 BD Business Overview
- 8.2.3 BD Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 BD Cardiovascular Diagnostic Testing Product Portfolio
- 8.2.5 BD Recent Developments
- 8.3 bioMérieux
- 8.3.1 bioMérieux Company Information
- 8.3.2 bioMérieux Business Overview
- 8.3.3 bioMérieux Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 bioMérieux Cardiovascular Diagnostic Testing Product Portfolio
- 8.3.5 bioMérieux Recent Developments
- 8.4 Bio-Rad Laboratories
- 8.4.1 Bio-Rad Laboratories Company Information
- 8.4.2 Bio-Rad Laboratories Business Overview
- 8.4.3 Bio-Rad Laboratories Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bio-Rad Laboratories Cardiovascular Diagnostic Testing Product Portfolio
- 8.4.5 Bio-Rad Laboratories Recent Developments
- 8.5 Danaher Corporation
- 8.5.1 Danaher Corporation Company Information
- 8.5.2 Danaher Corporation Business Overview
- 8.5.3 Danaher Corporation Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Danaher Corporation Cardiovascular Diagnostic Testing Product Portfolio
- 8.5.5 Danaher Corporation Recent Developments
- 8.6 F. Hoffmann-La Roche
- 8.6.1 F. Hoffmann-La Roche Company Information
- 8.6.2 F. Hoffmann-La Roche Business Overview
- 8.6.3 F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 F. Hoffmann-La Roche Cardiovascular Diagnostic Testing Product Portfolio
- 8.6.5 F. Hoffmann-La Roche Recent Developments
- 8.7 PerkinElmer
- 8.7.1 PerkinElmer Company Information
- 8.7.2 PerkinElmer Business Overview
- 8.7.3 PerkinElmer Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 PerkinElmer Cardiovascular Diagnostic Testing Product Portfolio
- 8.7.5 PerkinElmer Recent Developments
- 8.8 Siemens AG
- 8.8.1 Siemens AG Company Information
- 8.8.2 Siemens AG Business Overview
- 8.8.3 Siemens AG Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Siemens AG Cardiovascular Diagnostic Testing Product Portfolio
- 8.8.5 Siemens AG Recent Developments
- 8.9 Tosoh Corporation
- 8.9.1 Tosoh Corporation Company Information
- 8.9.2 Tosoh Corporation Business Overview
- 8.9.3 Tosoh Corporation Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Tosoh Corporation Cardiovascular Diagnostic Testing Product Portfolio
- 8.9.5 Tosoh Corporation Recent Developments
- 8.10 Thermo Fisher Scientific
- 8.10.1 Thermo Fisher Scientific Company Information
- 8.10.2 Thermo Fisher Scientific Business Overview
- 8.10.3 Thermo Fisher Scientific Cardiovascular Diagnostic Testing Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Thermo Fisher Scientific Cardiovascular Diagnostic Testing Product Portfolio
- 8.10.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cardiovascular Diagnostic Testing Value Chain Analysis
- 9.1.1 Cardiovascular Diagnostic Testing Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cardiovascular Diagnostic Testing Production Mode & Process
- 9.2 Cardiovascular Diagnostic Testing Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cardiovascular Diagnostic Testing Distributors
- 9.2.3 Cardiovascular Diagnostic Testing Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst